Medical Editor: John P. Cunha, DO, FACOEP
Trobicin (spectinomycin) For Injectable Suspension is an antibiotic used to treat gonorrhea. Common side effects of Trobicin include nausea, dizziness, soreness at the injection site, hives, insomnia, chills, and fever.
The recommended dosage of Trobicin is 2 grams. Other drugs may interact with Trobicin. Tell your doctor all medications you take. Your doctor should test you for syphilis before, during, and after you take Trobicin. If you are pregnant only take Trobicin if clearly needed. Exercise caution if you take Trobicin while breastfeeding.
Our Trobicin (spectinomycin) For Injectable Suspension, USP Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
The following reactions were observed during the single dose clinical trials: soreness at the injection site, urticaria, dizziness, nausea, chills, fever and insomnia.
During multiple dose subchronic tolerance studies in normal human volunteers, the following were noted: a decrease in hemoglobin, hematocrit and creatinine clearance; elevation of alkaline phosphatase, BUN and SGPT. In single and multiple dose studies in normal volunteers, a reduction in urine output was noted. Extensive renal function studies demonstrated no consistent changes indicative of renal toxicity.
A few cases of anaphylaxis or anaphylactoid reactions have been reported. If serious allergic reactions occur, the usual agents (epinephrine, corticosteroids, and/or antihistamines) should be available for emergency use. In cases of severe anaphylaxis, airway support and oxygen may also be required.
Read the entire FDA prescribing information for Trobicin (Spectinomycin)
© Trobicin Patient Information is supplied by Cerner Multum, Inc. and Trobicin Consumer information is supplied by First Databank, Inc., used under license and subject to their respective copyrights.